Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development

Recent progress in molecular imaging has provided new important knowledge for further understanding the time course of early pathological disease processes in Alzheimer's disease (AD). Positron emission tomography (PET) amyloid beta (Aβ) tracers such as Pittsburgh Compound B detect increasing d...

Descripción completa

Detalles Bibliográficos
Autor principal: Nordberg, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308023/
https://www.ncbi.nlm.nih.gov/pubmed/22136152
http://dx.doi.org/10.1186/alzrt96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308023/
https://www.ncbi.nlm.nih.gov/pubmed/22136152
http://dx.doi.org/10.1186/alzrt96

Ejemplares similares